Filmed on location in New York during the Great Debates and Updates in GI Malignancies 2015, this webcast is part of a series that provides educational discussions on controversial areas in the management of gastrointestinal malignancies. Join us as nationallyrecognized thought leaders take opposing sides on topics of clinical interest, and present updates in standards of care.

In this presentation, Dr. Jordan Berlin argues that JAK is the new standard after FOLFIRINOX.

© 2015 Imedex, LLC.